Aravive (ARAV) 10-Q2023 Q3 Quarterly report

Filed: 9 Nov 23, 4:05pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. sophomore Avg

New words: attached, bar, dropping, fraud, fraudulent, preempted, slight, statute, suspicion, unsuccessful, voluntary

Removed: acceptance, Administration, Agency, ancillary, April, AXL, biologic, biological, biomarker, bispecific, bundled, cabozantinib, capturing, care, CDE, Center, cGMP, chance, clearance, Committee, connective, construct, credited, CTGF, customary, decoy, delayed, demonstrated, denied, dependence, designated, designation, disbursed, discovery, disease, documentation, dose, dosed, EMA, enter, exclusivity, expansion, factor, Fast, favorable, fluctuated, Food, goal, government, halted, halting, healthy, immune, implicated, Importantly, IND, initiated, initiating, initiation, Institute, international, Investigational, Junior, kinase, larger, launch, Leader, Leland, line, long, mainland, matched, matching, measuring, mechanism, medical, Medicinal, neutralizing, NMPA, objective, offset, orphan, participate, pathway, perform, pharmacodynamic, pharmacokinetic, pharmacologically, platinum, PMDA, preclinically, preliminary, produce, profile, programming, promoting, proof, proprietary, protecting, protein, randomized, reaching, receptor, recognizing, recommendation, recurrent, referenced, registrational, reimbursement, repay, resistance, resistant, responding, role, run, screen, securing, serum, signal, signaling, significance, sublicense, sublicensing, substitute, suppression, survive, symposium, tangible, targeting, technical, technology, temporarily, therapeutic, therapy, tissue, track, typically, tyrosine, updated, utilize, work, WuXi, yearly

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

ARAV similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Rudy Howard, Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) of Aravive, Inc. (the “Company”), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

The Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2023 (the “Form 10-Q”) fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and

The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company for the periods presented.

Dated: November 9, 2023
	By:	/s/ Rudy Howard
		Name: Rudy Howard
		Title: Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.